glp-1 in development History of glucagon-like peptide-1 receptor agonists Evolution of GLP‐1 Receptor Agonists

Here's the thing: it's not about trying harder

That's your cancellation window

These medications work primarily by enhancing glucose-dependent insulin secretion, suppressing glucagon release when glucose levels are elevated, slowing gastric emptying, and reducing appetite through central nervous system pathways

November 22, 2024: Scientists Ask For More Research About Cancer Risks Associated with Zepbound and GLP-1 Drugs A recent study found that people who took GLP-1 drugs for 1 to 3 years were 58% more likely to develop thyroid cancers

GLP-1s May Prevent Rheumatic Disease From Developing A Harvard-led propensity-matched cohort study, also presented at ACR Convergence 2025 by Dr

Currently, only two RCTs have evaluated the efficacy of liraglutide at the approved dosage of 3.0 mg/day for the therapy of obesity